New cancer drug combo tested in japanese patients
NCT ID NCT06057038
First seen Nov 01, 2025 · Last updated Apr 23, 2026 · Updated 24 times
Summary
This early-stage study tests a new drug called GEN1042, alone or with other cancer treatments, in Japanese adults with solid tumors. The main goal is to check safety and find the right dose. About 42 participants will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cancer Center East
Kashiwa, Japan
-
National Cancer Center Hospital
Tokyo, Japan
-
Tokyo Medical University Hospital
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.